AZT - A BIOCHEMICAL RESPONSE MODIFIER OF METHOTREXATE AND 5-FLUOROURACIL CYTOTOXICITY IN HUMAN OVARIAN AND PANCREATIC-CARCINOMA CELLS

被引:38
作者
WEBER, G
NAGAI, M
PRAJDA, N
NAKAMURA, H
SZEKERES, T
OLAH, E
机构
来源
CANCER COMMUNICATIONS-US | 1991年 / 3卷 / 04期
关键词
D O I
10.3727/095535491820873407
中图分类号
学科分类号
摘要
In ovarian and pancreatic carcinoma cell lines, the activity of the salvage enzyme, thymidine kinase (EC 2.7.1.21), was 2- to 13-fold higher than that of the key enzyme of thymidylate de novo biosynthesis, thymidylate synthase (dTMP synthase, EC 2.1.1.45). AZT (3'-azido-3'-deoxythymidine, zidovudine) competitively inhibited thymidine kinase activity in extracts of human ovarian and pancreatic carcinoma cells, with Dixon plots yielding K(i) = 1.1-mu-M in both cell lines. AZT (20-mu-M) yielded synergistic cytotoxicity with methotrexate (0.4-mu-M) in human pancreatic carcinoma cells in clonogenic assay and also with methotrexate (0.02-mu-M) in human ovarian carcinoma cells, as measured by cell counts. Thymidine (10-mu-M) and hypoxanthine (100-mu-M) reversed these inhibitions. AZT (20 or 40-mu-M) also provided synergistic cytotoxicity with 5-fluorouracil (0.5 and 1.0-mu-M) in human pancreatic carcinoma cells in clonogenic assay. These studies suggest a new role for AZT, which, as an inhibitor of thymidine salvage, should be useful as a biochemical response modifier to provide a synergistic clinical anticancer impact on de novo biosynthesis of thymidylates in conjunction with methotrexate or 5-fluorouracil.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 17 条
  • [1] BRENNAN MF, 1989, CANCER PRINCIPLES PR, V1, P800
  • [2] PHOSPHORYLATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND SELECTIVE INTERACTION OF THE 5'-TRIPHOSPHATE WITH HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    FURMAN, PA
    FYFE, JA
    STCLAIR, MH
    WEINHOLD, K
    RIDEOUT, JL
    FREEMAN, GA
    LEHRMAN, SN
    BOLOGNESI, DP
    BRODER, S
    MITSUYA, H
    BARRY, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) : 8333 - 8337
  • [3] SIMPLE SEPARATION OF TRITIATED-WATER AND [H-3] DEOXYURIDINE FROM [5-H-3]DEOXYURIDINE 5'-MONOPHOSPHATE IN THE THYMIDYLATE SYNTHASE ASSAY
    HASHIMOTO, Y
    SHIOTANI, T
    WEBER, G
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 167 (02) : 340 - 346
  • [4] OLAH E, 1980, CANCER RES, V40, P2869
  • [5] PILLWEIN K, 1987, CANCER RES, V47, P3092
  • [6] METALLOTHIONEIN GENE-EXPRESSION AND RESISTANCE TO CISPLATIN IN HUMAN OVARIAN-CANCER
    SCHILDER, RJ
    HALL, L
    MONKS, A
    HANDEL, LM
    FORNACE, AJ
    OZOLS, RF
    FOJO, AT
    HAMILTON, TC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) : 416 - 422
  • [7] CHARACTERIZATION OF A NEW PRIMARY HUMAN PANCREATIC TUMOR LINE
    TAN, MH
    NOWAK, NJ
    LOOR, R
    OCHI, H
    SANDBERG, AA
    LOPEZ, C
    PICKREN, JW
    BERJIAN, R
    DOUGLASS, HO
    CHU, TM
    [J]. CANCER INVESTIGATION, 1986, 4 (01) : 15 - 23
  • [8] TIAZOFURIN - BIOLOGICAL EFFECTS AND CLINICAL USES
    TRICOT, G
    JAYARAM, HN
    WEBER, G
    HOFFMAN, R
    [J]. INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (03): : 161 - 170
  • [9] REGULATION OF DENOVO AND SALVAGE PATHWAYS IN CHEMOTHERAPY
    WEBER, G
    NAGAI, M
    NATSUMEDA, Y
    ICHIKAWA, S
    NAKAMURA, H
    EBLE, JN
    JAYARAM, HN
    ZHEN, W
    PAULIK, E
    HOFFMAN, R
    TRICOT, G
    [J]. ADVANCES IN ENZYME REGULATION, 1991, 31 : 45 - 67
  • [10] WEBER G, 1990, ADV ENZYME REGUL, V30, P35